DOCTOR ANALYTICAL LABORATORIES PVT. LTD.: PHARMA DIVISION
In this changing and developing scenario, things are changing rapidly to enhance the lives of this modern generation and upcoming generation and meet the necessary needs. While being fast and energetic around the clock, health needs to be perfect to perform extraordinarily. To maintain health in this competitive world, a name was brought to the industry that is Doctor Analytical Laboratories Pvt. Ltd. (DALPL) Pharma Division. Visionary, Mr. Ashay Mehta is the CEO and director of this reputed organization which is the Indian FDA (Maharastra) approved and registered & successfully inspected by USFDA.
THE INCEPTION OF THE DOCTOR ANALYTICAL LABS – PHARMA DIVISION
This division was started in the year 2017 with the candid vision to serve pharmaceutical companies that are serving and selling drugs in the regulated markets. Besides being audited by the US FDA and receiving EIR in April 2018, Doctor Analytical has been successfully audited and approved by numerous multinational pharma companies. These approvals became the strongest pillars and made the company ready to move forward with well-organized and specific testing services to serve the clients with accuracy and speed.Doctor Analytical (DALPL Pharma Division) has achieved a lot within a short period of time on the strength of its services and accountability which conveys the name of the company to the clients and builds the company up to this level.
THE TRUST FACTORS OF THE COMPANY
There are numerous reliable factors which authenticate the testings and results of the lab such as
- The lab has been successfully inspected by the US-FDA to render the services effectively.
- The processes are endowed with cGMP norms and regularly upgraded to meet the pre requisites.
- The infrastructure consist of the state of art facility housed with modern and advanced equipment including UPLC-MS/MS, ICPMS with a near-future plan in place for GCMSMS(Headspace), HPLC’s, GC to name a few.
- Strong team of Quality Assurance and Quality Control personel with a collective experience of more than 50 years.
GENOTOXIC IMPURITIES BY UPLCMSMS :
- Genotoxic Impurity Studies MD/MV and Batch Analysis
- Carryover Impurity Studies MD/MV and Batch Analysis
- Leechables & Extractable Studies (MD/MV & Regular Analysis
ELEMENTAL IMPURITIES BY ICP MS :
- Elemental Impurity Studies MD/MV and Batch Analysis
- Batch Release as USP 233
- Leechables & Extractables
At present, the company serves at various levels such as from medium to large size pharma corporations nationally and internationally. With modern-organized services and well-equipped facilities at the laboratory, Doctor Analytical has got valuable clientele such as Sanofi Aventis, Novartis, Lupin, Teva any many others.
THE VISION OF THE LAB
The growth and prosperity of any business lie in the vision and strategy which denote the success and make the foundation strong to stronger to meet the time and changes in the market. Doctor Analytical (DALPL) vision is to invest in the hyphenated technologies which are the advanced and modern technology to meet the demands of fast-changing and growing markets.
Apart from all the steps, the focus is constantly given on R&D which is one of the imperative aspects to make the company future-ready with upcoming challenges
and drastic changes. The company also remains focused on Method Development, Method Validation & Batch analysis for confirmation of Elemental Impurities, Genotoxic Impurities (Carcinogenic impurities) along with leechables and extractables.
The company is leaving nothing undone in this drastically changing world of technology to enrich the capacity and existing infrastructure. Therefore, it has been planned to add additional modern technology by the end of 2020 for Leechables/Extractables business lines.
THE WORKFORCE FOR THE VISION
Behind everything, a team of skilled employees works that make the foundation of the organization and future-ready to move ahead.Doctor Analytical (DALPL) is constantly focused to retain the employees’ content and motivated to deliver their potential to contribute to the success of the company. The company also promotes and makes them a part of the big picture as well as talk to them time to time about the present and future plans of the company. To ease the work-life balance and facilitate the employees with modern technology, all the possible efforts are made to fulfill the demands of the industry.
